-
-
Recent Posts
- Coronavirus today and the SCI community tomorrow
- Stroke Drug Boosts Stem Cell Therapy For Spinal Cord Injury In Rats
- An integrated in silico pipeline identifies a novel TF combination that promotes enhanced CST growth following injury
- Spike timing-dependent plasticity in the adult rat with chronic cervical spinal cord contusion
- Effect of PTEN antagonist peptide on the functional motor recovery in rat
- GDF10 promotes axonal regeneration and functional recovery: A novel gene therapy strategy for spinal cord injury
- GTX Medical and NeuroRecovery Technologies to merge
- Candidate Therapy From Quebec for Chronic SCI Being Developed in Parallel by Academics and Companies in Switzerland and the Netherlands
- Moving beyond the glial scar for spinal cord repair
- The Struggle to Make CNS Axons Regenerate: Why Has It Been so Difficult?
- The potential of electric field for promoting neurite guidance in spinal cord injury regeneration strategies
- Extraction and selective activation of muscle synergies through spinal stimulation for SCI
- Early limb unloading elicits long-term motor deficits involving motorneuron hyperexcitability associated with persistent alterations in glutamatergic synaptic plasticity in spinal cord injury
- The effects of a pro-angiogenic, RGD-functionalized, nanofiber composite biomaterial on mesenchymal stem cell-mediated repair of the injured spinal cord
- From wheelchair to walking after spinal cord injury
Follow on Twitter
My TweetsSpinal Cord Injury Research and Science at Facebook
Categories
Archives
Tag Archives: Alliance for Regenerative Medicine
Alliance for Regenerative Medicine (ARM) Neuralstem Presentation
Alliance for Regenerative Medicine (ARM) Neuralstem Presentation April 17, 2018 Neuralstem is a clinical-stage biopharmaceutical company developing novel treatments for nervous system diseases of high unmet medical need. The company’s lead asset and stem cell therapy candidate, NSI-566, is a … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged Alliance for Regenerative Medicine, Neuralstem
Comments Off on Alliance for Regenerative Medicine (ARM) Neuralstem Presentation
InVivo Therapeutics at Meeting on the Mesa
InVivo Therapeutics Video Presentation at Alliance for Regenerative Medicine 6th Annual Partnering Forum Tom Ulich, M.D., Chief Scientific Officer, Cambridge, MA (NASDAQ: NVIV)
Posted in Biomaterials, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research
Tagged Alliance for Regenerative Medicine, InVivo Therapeutics, Tom Ulich M.D.
Comments Off on InVivo Therapeutics at Meeting on the Mesa
Alliance for Regenerative Medicine: Stem Cells 2014
Presented by: Teresa Leezer, CEO RhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will change the way neurodegenerative disorders are treated. Founded in 2005, the Company is advancing innovative treatment paradigms that leverage proprietary … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research
Tagged Alliance for Regenerative Medicine, Asterias Biotherapeutics, InVivo Therapeutics, RhinoCyte, Stem Cells Inc
Comments Off on Alliance for Regenerative Medicine: Stem Cells 2014
Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)
Martin McGlynn, President and CEO of Stem Cells Inc. gives an update on Investor Day in New York City. For spinal cord injury they plan to release data in the second quarter of 2014 and open 20-30 additional sites to … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research
Tagged Alliance for Regenerative Medicine, Martin McGlynn, Stem Cells Inc
Comments Off on Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)
CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field … Continue reading
Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research
Tagged Alliance for Regenerative Medicine, axon regeneration, chronic spinal cord injury, clinical trials spinal cord injury, Dr. Aileen Anderson, Dr. Stephen Huhn, embryonic stem cells, locomotion, Martin McGlynn, motor function, neurite growth, paralysis, regeneration, spinal cord injury, spinal cord injury research, stem cell therapy, StemCells Inc, U2FP, Unite 2 Fight Paralysis, Unite2FightParalysis
Comments Off on CNS Panel Discussion, StemCells Inc. and Asterias Biotherapeutics at Alliance for Regenerative Medicine Investor Day
Time for Some Bold Steps: Why We Need a National Strategy and Initiative in Regenerative Medicine and What It Could Include
Dr. Gil Van Bokkelen Chairman, Alliance for Regenerative Medicine There is intense public interest in the medical potential of regenerative medicine, and in my opinion for very good reason. Those of us that are actively engaged in and/or closely follow … Continue reading
SPINAL CORD INJURY RESEARCH AND SCIENCE 